Utilidad del tacto rectal en pacientes con cáncer de próstata y antígeno prostático menor a 4 ng/ml

Fullá, Juan; Sotelo, Danilo; García, Vicente; Oyanedel, Felipe; Sánchez, Catherine; Ramos, Christian; Mercado, Alejandro; Ebensperguer, Mauricio; Nicolai, Heinz; Fleck, Daniela.
Rev. chil. urol ; 79(4): 63-65, 2014. tab
Artículo en Español | LILACS | ID: lil-785418

Documentos relacionados

  1. Prostate cancer screening - is it time to change approach?
  2. SERS-Temperature Dual-Mode T-type Lateral Flow Strip for Accurate Detection of Free and Total Prostate-Specific Antigens in Blood.
  3. Clinical utility of multiple secondary combined tests in prostate cancer screening.
  4. Factors affecting the diagnosis of prostate cancer through 12 quadrant guided prostate biopsy.
  5. Prostate cancer mortality rates in low- and favorable intermediate-risk active surveillance patients: a population-based competing risks analysis.
  6. Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort.
  7. Shifting risk-stratified early prostate cancer detection to a primary healthcare setting.
  8. Development and Validation of a Prostate Biopsy Risk Calculator in Black Men.
  9. A west African ancestry-associated SNP on 8q24 predicts a positive biopsy in African American men with suspected prostate cancer following PSA screening.
  10. Preanalytical stability of molecular forms of prostate-specific antigen in serum samples (PSA, free PSA, [-2]proPSA) and their impact on fPSA/tPSA ratio and PHI.